Comparative Analysis of Letrozole vs. Clomiphene Citrate in Women with PCOS Undergoing Ovulation Induction
DOI:
https://doi.org/10.63682/jns.v13i1.9357Keywords:
Polycystic ovary syndrome, Letrozole, Clomiphene Citrate, Ovulation induction, Infertility, Pregnancy outcomesAbstract
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder leading to anovulatory infertility. Both Clomiphene Citrate and Letrozole are widely used for ovulation induction, but their relative effectiveness remains a subject of debate.
Methods: A prospective comparative study was conducted at Department of Gynaecology and obstetrics Dr Ziauddin university Karachi from February 2023 to February 2024. A total of 71 women with PCOS were enrolled and randomly assigned to two groups: Group A (n=36) received Letrozole, while Group B (n=35) received Clomiphene Citrate. Patients were monitored with transvaginal ultrasonography for follicular growth, endometrial thickness, and ovulation. Outcomes assessed included ovulation rate, endometrial response, biochemical pregnancy, clinical pregnancy, live birth, and adverse effects. Data were analyzed using SPSS version 26, with p<0.05 considered significant.
Results: Baseline demographic and hormonal profiles were similar across groups. Women treated with Letrozole developed a thicker endometrium than those receiving Clomiphene (8.7 ± 1.2 mm versus 7.3 ± 1.4 mm, p=0.001). Clomiphene induced a higher mean number of mature follicles (2.4 ± 0.8 vs. 1.8 ± 0.6, p=0.004). Ovulation and pregnancy rates were higher with Letrozole, though not statistically significant. Adverse effects such as ovarian cyst formation and hot flushes were more common in the Clomiphene group.
Conclusion: Letrozole demonstrated superior endometrial development, comparable follicular response, and a trend toward better pregnancy outcomes with fewer adverse ‘effects compared to Clomiphene Citrate’. These findings support the use of Letrozole as a preferred first-line agent for ovulation induction in women with PCOS.
Downloads
References
Sharif, N., et al., Comparison of letrozole and clomiphene citrate efficacy in terms of ovulation induction and pregnancy rate. 2021. 28(05): p. 749-754.
Shil, A., et al., Letrozole Versus Clomiphene Citrate As Ovulation Inducing Agents For Infertility In Women With Polycystic Ovary Syndrome-A-Systematic Review Article. 2022. 5(4): p. 1081.
Kabadi, Y.K.M. and P.S.J.T.N.I.J.o.O. Madinoor, Randomized interventional clinical trial to estimate the efficacy of clomiphene citrate versus letrozole in induction of ovulation in infertility. 2022. 9(1): p. 94-8.
Khodary, M.M., et al., Letrozole and Clomiphene citrate versus Letrozole alone in ovulation induction for patients with Polycystic Ovarian Syndrome. 2022. 5(2): p. 27-34.
Asgharnia, M., et al., The efficiency of low‐dose letrozole plus clomiphene citrate for ovulation induction in intrauterine insemination cycles: A randomized clinical trial. 2022. 159(1): p. 182-187.
Farzaneh, F. and F.J.I.J.o.R.B. Afshar, Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: An RCT. 2020. 18(4): p. 307.
Ali, A.I., A.E.-A.M. Ahmed, and A.A.J.A.-A.A.M.J. Elboghdady, Comparing the effect of gonadotropin versus letrozole for induction of ovulation in patients with polycystic ovary syndrome with clomiphene citrate failure. 2022. 20(1): p. 93-99.
Ahmed Abdalla, M., et al., Clomiphene Citrate versus Letrozole for Induction of Ovulation in Infertile women having Polycystic Ovarian Syndrome (Randomized Controlled Trial). 2021. 4(7).
Ay, S.S., et al., Efficacy of letrozole versus clomiphene citrate for infertile women with polycystic ovary syndrome. 2021. 10(8): p. 2944-50.
Begum, P., et al., Efficacy and side effects of letrozole over clomiphene citrate for ovulation induction of the patients with PCOS: a randomized controlled trial. 2020. 15(2): p. 69-73.
Vyrides, A.A., E. El Mahdi, and K.J.F.i.M. Giannakou, Ovulation induction techniques in women with polycystic ovary syndrome. 2022. 9: p. 982230.
Abduljabbar, H.S., M. Hagras, and R. Magadmy, Effect of aromatase inhibitors versus clomiphene citrate for ovulation induction in infertile women with ovulatory dysfunction (PCO), in Polycystic Ovarian Syndrome. 2020, IntechOpen.
Wang, L., et al., Letrozole versus clomiphene citrate and natural cycle: endometrial receptivity during implantation window in women with polycystic ovary syndrome. 2021. 11: p. 532692.
Lotfy, M., et al., GONADOTROPINS-LETROZOLE, GONADOTROPIN-CLOMIPHENE CITRATE, AND GONADOTROPINS ONLY FOR CONTROLLED OVARIAN SUPER STIMULATION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME UNDERGOING INTRACYTOPLASMIC SPERM INJECTION. 2022. 13.
Jasim Mahmood, D., et al., Comparison Between Preovulatory Follicular Pulsed Doppler Indices Under the Effect of Mild Ovarian Stimulation by Clomiphene Citrate vs Letrozole. 2021. 10(1).
Qin, F., et al., Comparison of clomiphene and letrozole for superovulation in patients with unexplained infertility undergoing intrauterine insemination: A systematic review and meta-analysis. 2020. 99(31): p. e21006.
Kindy, S.M., et al., Letrozole versus clomiphene citrate with metformin for induction of ovulation in obese patients with polycystic ovarian disease. 2020. 26(4): p. 582-589.
Mahmuda, U.K., et al., Endometrial changes in Infertile Women with Polycystic Ovary Syndrome after taking Letrozole in Comparison to Clomiphene Citrate. 2022. 37(1): p. 5-13.
Bashir, B., M. Nisar, and S.J.K.J.o.M.S. Akbar, To Compare the Efficacy of Clomid and Letrozole in Polycystic Ovary Syndrome. 2021. 14(1): p. 53-58.
Ashry, H., T. Aly, and A.J.E.B.W.s.H.J. Ragab, Comparison Between Letrozole With and Without Gonadotropins Injection on Pregnancy Rates in Infertile PCOS Patients: A Multicenter Randomized Observational Trial. 2022. 12(2): p. 157-165.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
